Your browser version may not work well with NCBI's Web applications. More information here...

Recent Activity

Items 1 - 20 of 103
of 6Next
1:

Dendritic cell defects in patients with cancer: mechanisms and significance.

Lenahan C, Avigan D.

Breast Cancer Res. 2006;8(1):101. Epub 2006 Jan 5.

PMID: 16469120 [PubMed - indexed for MEDLINE]

2:

Spontaneous apoptosis of blood dendritic cells in patients with breast cancer.

Pinzon-Charry A, Maxwell T, McGuckin MA, Schmidt C, Furnival C, López JA.

Breast Cancer Res. 2006;8(1):R5. Epub 2005 Dec 16.

PMID: 16417648 [PubMed - indexed for MEDLINE]

3:

The key role of CD40 ligand in overcoming tumor-induced dendritic cell dysfunction.

Pinzon-Charry A, Schmidt CW, López JA.

Breast Cancer Res. 2006;8(1):402. Epub 2006 Feb 22.

PMID: 16524455 [PubMed - indexed for MEDLINE]

4:

Dendritic cell-tumor cell hybrids enhance the induction of cytotoxic T lymphocytes against murine colon cancer: a comparative analysis of antigen loading methods for the vaccination of immunotherapeutic dendritic cells.

Yasuda T, Kamigaki T, Nakamura T, Imanishi T, Hayashi S, Kawasaki K, Takase S, Ajiki T, Kuroda Y.

Oncol Rep. 2006 Dec;16(6):1317-24.

PMID: 17089056 [PubMed - indexed for MEDLINE]

5:

Numerical and functional defects of blood dendritic cells in early- and late-stage breast cancer.

Pinzon-Charry A, Ho CS, Maxwell T, McGuckin MA, Schmidt C, Furnival C, Pyke CM, López JA.

Br J Cancer. 2007 Nov 5;97(9):1251-9. Epub 2007 Oct 9.

PMID: 17923873 [PubMed - indexed for MEDLINE]

6:

Vascular endothelial growth factor inhibits the function of human mature dendritic cells mediated by VEGF receptor-2.

Mimura K, Kono K, Takahashi A, Kawaguchi Y, Fujii H.

Cancer Immunol Immunother. 2007 Jun;56(6):761-70. Epub 2006 Nov 4.

PMID: 17086423 [PubMed - indexed for MEDLINE]

7:

Dendritic cell-based therapeutics for breast cancer.

Pilon-Thomas SA, Verhaegen ME, Mulé JJ.

Breast Dis. 2004;20:65-71. Review.

PMID: 15687708 [PubMed - indexed for MEDLINE]

8:

Induction of cytolytic T lymphocytes against pediatric solid tumors in vitro using autologous dendritic cells pulsed with necrotic primary tumor.

Shilyansky J, Jacobs P, Doffek K, Sugg SL.

J Pediatr Surg. 2007 Jan;42(1):54-61; discussion 61.

PMID: 17208541 [PubMed - indexed for MEDLINE]

9:

Virology- and immunology-based gene therapy for cancer.

Tagawa M, Kawamura K, Shimozato O, Ma G, Li Q, Suzuki N, Shimada H, Ochiai T.

Cancer Immunol Immunother. 2006 Nov;55(11):1420-5. Epub 2006 May 12. Review.

PMID: 16691360 [PubMed - indexed for MEDLINE]

10:

Mature dendritic cells generated from patient-derived peripheral blood monocytes in one-step culture using streptococcal preparation OK-432 exert an enhanced antigen-presenting capacity.

Naito K, Ueda Y, Itoh T, Fuji N, Shimizu K, Yano Y, Yamamoto Y, Imura K, Kohara J, Iwamoto A, Shiozaki A, Tamai H, Shimizu T, Mazda O, Yamagishi H.

Int J Oncol. 2006 Jun;28(6):1481-9.

PMID: 16685449 [PubMed - indexed for MEDLINE]

11:

An ex vivo readout for evaluation of dendritic cell-induced autologous cytotoxic T lymphocyte responses against esophageal cancer.

Milano F, Rygiel AM, Buttar N, Bergman JJ, Sondermeijer C, van Baal JW, ten Brinke A, Kapsenberg M, van Ham SM, Peppelenbosch MP, Krishnadath KK.

Cancer Immunol Immunother. 2007 Dec;56(12):1967-77. Epub 2007 Jun 13.

PMID: 17564704 [PubMed - indexed for MEDLINE]

12:

Preparation of fully activated dendritic cells capable of priming tumor-specific cytotoxic T lymphocytes in patients with metastatic cancer using penicillin-killed streptococcus pyogenes (OK432) and anti-CD40 antibody.

Kontani K, Teramoto K, Ozaki Y, Sawai S, Tezuka N, Ishida H, Kajino K, Fujino S, Yamauchi A, Taguchi O, Kannagi R, Yokomise H, Ogasawara K.

Oncol Rep. 2007 Apr;17(4):895-902.

PMID: 17342333 [PubMed - indexed for MEDLINE]

13:

Flt3 ligand promotes myeloid dendritic cell differentiation of human hematopoietic progenitor cells: possible application for cancer immunotherapy.

Harada S, Kimura T, Fujiki H, Nakagawa H, Ueda Y, Itoh T, Yamagishi H, Sonoda Y.

Int J Oncol. 2007 Jun;30(6):1461-8.

PMID: 17487367 [PubMed - indexed for MEDLINE]

14:

Induction of tumor-specific T-cell responses by vaccination with tumor lysate-loaded dendritic cells in colorectal cancer patients with carcinoembryonic-antigen positive tumors.

Tamir A, Basagila E, Kagahzian A, Jiao L, Jensen S, Nicholls J, Tate P, Stamp G, Farzaneh F, Harrison P, Stauss H, George AJ, Habib N, Lechler RI, Lombardi G.

Cancer Immunol Immunother. 2007 Dec;56(12):2003-16. Epub 2007 Feb 23.

PMID: 17333181 [PubMed - indexed for MEDLINE]

15:

Cancer immunotherapy using dendritic/tumour-fusion vaccine induces elevation of serum anti-nuclear antibody with better clinical responses.

Homma S, Sagawa Y, Ito M, Ohno T, Toda G.

Clin Exp Immunol. 2006 Apr;144(1):41-7.

PMID: 16542363 [PubMed - indexed for MEDLINE]

16:

A crucial role for dendritic cell (DC) IL-10 in inhibiting successful DC-based immunotherapy: superior antitumor immunity against hepatocellular carcinoma evoked by DC devoid of IL-10.

Chen YX, Man K, Ling GS, Chen Y, Sun BS, Cheng Q, Wong OH, Lo CK, Ng IO, Chan LC, Lau GK, Lin CL, Huang F, Huang FP.

J Immunol. 2007 Nov 1;179(9):6009-15.

PMID: 17947674 [PubMed - indexed for MEDLINE]

17:

Induction of cytotoxic T lymphocytes against human cancer cell lines using dendritic cell-tumor cell hybrids generated by a newly developed electrofusion technique.

Imura K, Ueda Y, Hayashi T, Itoh T, Shimizu K, Tamai H, Yano Y, Naito K, Kohara J, Nakane K, Matsuura Y, Takeda A, Takeda T, Kawai K, Yamagishi H.

Int J Oncol. 2006 Sep;29(3):531-9.

PMID: 16865268 [PubMed - indexed for MEDLINE]

18:

[Immunotherapeutic effects of beta-elemene combined with interleukin-23 gene-modified dendritic cells on murine pancreatic carcinoma]

Tan G, Wang ZY, Wang XG, Cheng L, Yin S.

Ai Zheng. 2006 Sep;25(9):1082-6. Chinese.

PMID: 16965646 [PubMed - indexed for MEDLINE]

19:

Successful induction of clinically competent dendritic cells from granulocyte colony-stimulating factor-mobilized monocytes for cancer vaccine therapy.

Ueda Y, Itoh T, Fuji N, Harada S, Fujiki H, Shimizu K, Shiozaki A, Iwamoto A, Shimizu T, Mazda O, Kimura T, Sonoda Y, Taniwaki M, Yamagishi H.

Cancer Immunol Immunother. 2007 Mar;56(3):381-9. Epub 2006 Jul 8.

PMID: 16830156 [PubMed - indexed for MEDLINE]

20:

Splenic dendritic cells pulsed with Ixodes ricinus tick saliva prime naive CD4+T to induce Th2 cell differentiation in vitro and in vivo.

Mejri N, Brossard M.

Int Immunol. 2007 Apr;19(4):535-43. Epub 2007 Mar 6.

PMID: 17344202 [PubMed - indexed for MEDLINE]

Items 1 - 20 of 103
of 6Next